BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Ajanta Pharma Ltd Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
532331
ISIN Demat
INE031B01049
Book Value (Rs)
330.3875196
NSE Symbol
AJANTPHARM
Divident Yield %
0.96
Market Cap
(Rs In Cr.)
36,468
P/E (TTM)
38.67
EPS (TTM)
75.48
Face Value
(Rs)
2
Back
Ajanta Pharma consolidated net profit rises 20.19% in the September 2025 quarter
03-Nov-25   Hrs IST

Net profit of Ajanta Pharma rose 20.19% to Rs 260.19 crore in the quarter ended September 2025 as against Rs 216.48 crore during the previous quarter ended September 2024. Sales rose 14.08% to Rs 1353.73 crore in the quarter ended September 2025 as against Rs 1186.64 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales1353.731186.64 14
OPM %24.2226.22 -
PBDT383.78324.63 18
PBT340.81290.24 17
NP260.19216.48 20

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)